Integrating the expertise of large, small, and medium-sized enterprises with academic knowledge to create an innovative platform that, through the definition and activation of an experimental development plan, will advance the search for new drugs to treat Central Nervous System (CNS) and oncological diseases.
This is the goal of the Neon project.
Dompé Farmaceutici leads this scientific consortium, bringing together organizations and companies recognized for excellence in their respective fields.
The consortium includes prominent institutions such as Vita-Salute San Raffaele University, the University of Milan, Politecnico di Milano, the European Institute of Oncology, the CNR Institute of Neurosciences, the Italian Institute of Technology, Proxentia, and Neuro-Zone.
